[HTML][HTML] Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions

MV Fogaça, RS Duman - Frontiers in cellular neuroscience, 2019 - frontiersin.org
Major depressive disorder (MDD) is a debilitating illness characterized by neuroanatomical
and functional alterations in limbic structures, notably the prefrontal cortex (PFC), that can be …

Brain NMDA receptors in schizophrenia and depression

A Adell - Biomolecules, 2020 - mdpi.com
N-methyl-D-aspartate (NMDA) receptor antagonists such as phencyclidine (PCP),
dizocilpine (MK-801) and ketamine have long been considered a model of schizophrenia …

Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression

S Ghosal, BD Hare, RS Duman - Current opinion in behavioral sciences, 2017 - Elsevier
Highlights•Chronic stress causes atrophy and decreased connectivity of excitatory neurons
in PFC.•Stress causes disruption of GABAergic inhibitory neurons in the PFC.•GABA …

Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic …

AL Pehrson, C Sanchez - Drug design, development and therapy, 2015 - Taylor & Francis
Evidence suggesting that central nervous system γ-aminobutyric acid (GABA)
concentrations are reduced in patients with major depressive disorder (MDD) has been …

GABAergic control of depression-related brain states

B Luscher, T Fuchs - Advances in pharmacology, 2015 - Elsevier
The GABAergic deficit hypothesis of major depressive disorders (MDDs) posits that reduced
γ-aminobutyric acid (GABA) concentration in brain, impaired function of GABAergic …

M1 acetylcholine receptors in somatostatin interneurons contribute to GABAergic and glutamatergic plasticity in the mPFC and antidepressant-like responses

MV Fogaça, M Wu, C Li, XY Li, RS Duman… - …, 2023 - nature.com
Alterations in glutamatergic and GABAergic function in the medial prefrontal cortex (mPFC)
are prevalent in individuals with major depressive disorder, resulting in impaired synaptic …

The change in plasma GABA, glutamine and glutamate levels in fluoxetine-or S-citalopram-treated female patients with major depression

E Küçükibrahimoğlu, MZ Saygın, M Çalışkan… - European journal of …, 2009 - Springer
Objective The aim of this study was to investigate the relationship between plasma
glutamate, glutamine and γ-aminobutyric acid (GABA) levels in female patients with major …

The role of the excitation: inhibition functional balance in the mPFC in the onset of antidepressants

YY Yin, YH Wang, WG Liu, JQ Yao, J Yuan, ZH Li… - …, 2021 - Elsevier
Currently available antidepressants, such as selective serotonin reuptake inhibitors (SSRIs)
and serotonin and norepinephrine reuptake inhibitors (SNRIs), generally require weeks to …

Cardamom oil ameliorates behavioral and neuropathological disorders in a rat model of depression induced by reserpine

AA Abdel-Rasoul, NA Saleh, EN Hosny… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Depression is a public health problem. Despite the
availability of treatment options, its prevalence is increasing. A high rate of treatment failure …

A preliminary transcranial magnetic stimulation study of cortical inhibition and excitability in high‐functioning autism and Asperger disorder

PG Enticott, NJ Rinehart, BJ Tonge… - … Medicine & Child …, 2010 - Wiley Online Library
Aim Controversy surrounds the distinction between high‐functioning autism (HFA) and
Asperger disorder, but motor abnormalities are associated features of both conditions. This …